David Stevenson, MD, FACMG

Stanford University Pediatrics Medical Genetics
Palo Alto, California, United States

Disclosure information not submitted.

Presentation(s):

• SUN-688 - Long-Term Reductions of Hyperphagia with Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-689 - Efficacy and Safety of Resuming Diazoxide Choline Extended-Release (DCCR) after 16-week Randomized Withdrawal in Prader-Willi Syndrome (PWS) (Study C614)

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• MON-690 - Impact of Long-Term Diazoxide Choline Extended Release (DCCR) Treatment and the Prader-Willi Syndrome Profile Questionnaire (PWSP)

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• ORF44-02 - Impact of Long-Term Diazoxide Choline Extended Release (DCCR) Treatment and the Prader-Willi Syndrome Profile Questionnaire (PWSP)

  Monday, June 15, 2026
  9:35 AM - 9:40 AM CT